Comparison Between External and Internal Imputation of Missing Values in Longitudinal Data for Alzheimer's Disease Diagnosis
Year: 2024
Type: conference-paper
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: U.S. Department of Defense, Alzheimer's Association, Bristol-Myers Squibb, Alzheimer's Drug Discovery Foundation, Eli Lilly and Company, Pfizer, Merck, Roche, Biogen, AbbVie, Meso Scale Diagnostics, Alzheimer's Disease Neuroimaging Initiative, Takeda Pharmaceuticals U.S.A., BioClinica, Novartis Pharmaceuticals Corporation, Fujirebio US, Eisai, Ministerio de Ciencia e Innovación, Servier, H. Lundbeck A/S, IXICO, National Institutes of Health, Genentech, GE Healthcare, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Johnson and Johnson Pharmaceutical Research and Development, Janssen Alzheimer Immunotherapy Research And Development
OpenAlex ID: W4405756243